MAIA Biotechnology (MAIA) EBT (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly EBT of -$7.3 million for Q1 2026, down 30.46% year-over-year from -$10.5 million in Q1 2025, and up 73.24% quarter-over-quarter from -$27.2 million in Q4 2025.
MAIA Biotechnology (MAIA) EBT (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported EBT for 6 consecutive years, with -$7.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 30.46% year-over-year to -$7.3 million; the TTM figure through Mar 2026 stood at -$49.8 million (down 34.77% YoY), while the FY2025 annual figure was -$47.2 million, down 48.15% from the prior year.
- EBT rose to -$7.3 million in Q1 2026 per MAIA's latest filing, from -$27.2 million in the prior quarter.
- Across five years, EBT topped out at -$3.4 million in Q1 2022 and bottomed at -$27.2 million in Q4 2025.
- Historically, EBT has averaged -$9.9 million across 5 years, with a median of -$7.1 million in 2023.
- Annual changes were most pronounced in 2023 — EBT jumped 67.31% — and 2025, when it sank 452.32%.
- MAIA Biotechnology's EBT stood at -$4.2 million in 2022, then plunged by 51.14% to -$6.3 million in 2023, then grew by 22.41% to -$4.9 million in 2024, then tumbled by 452.32% to -$27.2 million in 2025, then soared by 73.24% to -$7.3 million in 2026.
- Business Quant data shows MAIA's EBT at -$7.3 million in Q1 2026, -$27.2 million in Q4 2025, and -$9.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 81.49 Mn |
| 10 | MAIA Biotechnology | 85.42 Mn | 57.82 Mn | - | -8.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.83 Mn |
| Mar 31, 2026 | -7.28 Mn |
| Dec 31, 2025 | -27.20 Mn |
| Sep 30, 2025 | -9.61 Mn |
| Jun 30, 2025 | -5.71 Mn |
| Mar 31, 2025 | -5.58 Mn |
| Dec 31, 2024 | -4.92 Mn |
| Sep 30, 2024 | -11.12 Mn |
| Jun 30, 2024 | -15.33 Mn |
| Mar 31, 2024 | -6.49 Mn |
| Dec 31, 2023 | -6.35 Mn |
| Sep 30, 2023 | -7.08 Mn |
| Jun 30, 2023 | -6.77 Mn |
| Mar 31, 2023 | -13.09 Mn |
| Dec 31, 2022 | -4.20 Mn |
| Sep 30, 2022 | -13.63 Mn |
| Jun 30, 2022 | -20.71 Mn |
| Mar 31, 2022 | -3.44 Mn |
| Dec 31, 2021 | -3.00 Mn |
| Sep 30, 2021 | -2.68 Mn |